Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked -- Ignore unavailable to you. Want to Upgrade?

To: Dave who wrote (49085)	6/4/1999 11:45:00 PM
From: Mark_H	Respond to of 90042

Thanks. The stock took a nose dive yesterday (Thursday)and I'm not exactly sure why. ANIK tried to get FDA approval last year for a product similar to Synvisc and the BXM stock dropped below $25 and I was able to get back in around $28 (pre split). The FDA did not approve ANIK's product and BXM recovered nicely. The drop yesterday was unexpected and I thought if you followed the stock or similar biotechs that you might know of something going on in the arthritis drug area.